Taison Group Planning 600,000 mtpy of Tissue, Graphic Paper and Bamboo Pulp Capacity
Print this Article | Send to Colleague
The Taison Group is planning to build 150,000 mtpy of bamboo pulp, 250,000 mtpy of tissue paper and 200,000 mtpy of uncoated fine paper (UFP) capacity in Leshan city, in China’s southwestern province of Sichuan.
The projects will be carried out at existing mills run by Sichuan Yongfeng Paper, the largest bamboo pulp producer in the country and an indirect subsidiary of the Taison Group since 2018.
Environmental impact assessment (EIA) reports on the pulp and paper expansion scheme were published last week, and they are now open to advice from the public.
According to the EIA documents, Sichuan Yongfeng will build a new 150,000-mtpy unbleached bamboo pulp line at a pulp mill in Muchuan county.
At present, the plant runs a 200,000-mtpy bamboo pulp line. Around 75 percent of its output is processed into dry pulp sheets and sold on the market.
The remaining pulp is consumed by a tissue mill nearby, which is run by Sichuan Hefeng Paper, a wholly-owned subsidiary of Sichuan Yongfeng.
Currently the plant houses dozens of small tissue machines with a total capacity of 50,000 mtpy.
The company plans to replace all of them with 18 new units with a combined tissue paper capacity of 250,000 mtpy.
Each machine will have a trim width of 2.85 m.
The proposed bamboo pulp capacity will feed the new tissue PMs, with surplus to be sold on the market.
The Taison Group is also eyeing pulp and paper expansions in Nanping city, in the southeastern province of Fujian.
The group recently signed an RMB 5.8 billion ($819 million) investment plan with the government of Nanping to build a new integrated pulp and paper complex there.
The proposed facility will include 450,000 mtpy of bamboo pulp capacity, 300,000 mtpy tissue paper capacity and 200,000 mtpy UFP capacity.
The investment plan is associated with the Nanping city government’s move to dispose of the idled, heavily-indebted Fujian Nanping Paper, though the local authority has not revealed any details. Back to Tissue360 Newsletter |